News
June 4, 2020
A new technology based on Nano-Pulse Stimulation (NPS) appears to be effective for treating a growing list of benign dermatologic indications, and now it’s being investigated for nonmelanoma skin cancer, one expert says. With potentially fewer side effects, this technology has definitive advantages over traditional modalities that may make it an excellent treatment alternative in the future, says E. Victor Ross, M.D., Scripps Clinic Carmel Valley, Laser & Cosmetic Dermatology, San Diego, Calif., who spoke during the ODAC meeting in Orlando.
“Nano-pulse stimulation is an exciting new technology that likely has only touched the surface of its potential therapeutic utility in dermatology,” he says. “Beyond its proven efficacy in benign dermatologic lesions, this technology could potentially also prove useful in the treatment of nonmelanoma skin cancer such as basal cell carcinoma.”